DK115842B - Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.Info
- Publication number
- DK115842B DK115842B DK315765AA DK315765A DK115842B DK 115842 B DK115842 B DK 115842B DK 315765A A DK315765A A DK 315765AA DK 315765 A DK315765 A DK 315765A DK 115842 B DK115842 B DK 115842B
- Authority
- DK
- Denmark
- Prior art keywords
- aminobutynylsuccinimides
- aminobutynylglutarimides
- preparation
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8163/64A SE300422B (da) | 1964-07-03 | 1964-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK115842B true DK115842B (da) | 1969-11-17 |
Family
ID=20273317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK315765AA DK115842B (da) | 1964-07-03 | 1965-06-22 | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3444171A (da) |
| DK (1) | DK115842B (da) |
| FI (1) | FI45043C (da) |
| GB (1) | GB1079467A (da) |
| SE (1) | SE300422B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4065471A (en) * | 1965-04-09 | 1977-12-27 | Sterling Drug Inc. | N-(4-Amino-2-butynyl)imides |
| US3862130A (en) * | 1970-04-27 | 1975-01-21 | Goodrich Co B F | Alkylhydroxyp henylcarboalkoxy-substituted nitrogen heterocycles |
| DE2411019C2 (de) * | 1973-03-16 | 1986-11-20 | Nelson Research & Development Co., Irvine, Calif. | Verwendung von 1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinon oder 1-(2-Oxo-1-pyrrolidin)-4-(1-pyrrolidin)-2-butyn zur Behandlung von Glaucoma |
| PL152958B1 (en) * | 1987-02-25 | 1991-02-28 | Egyt Gyogyszervegyeszeti Gyar | Method for manufacturing piperazine derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL255251A (da) * | 1959-08-28 | |||
| US3317526A (en) * | 1964-07-16 | 1967-05-02 | Astra Ab | Omega-tertiaryamino butynol-1-phenylcycloalkane carboxylates |
| US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
-
1964
- 1964-07-03 SE SE8163/64A patent/SE300422B/xx unknown
-
1965
- 1965-06-17 GB GB25740/65A patent/GB1079467A/en not_active Expired
- 1965-06-22 DK DK315765AA patent/DK115842B/da unknown
- 1965-07-02 FI FI651576A patent/FI45043C/fi active
-
1966
- 1966-12-30 US US606063A patent/US3444171A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3444171A (en) | 1969-05-13 |
| SE300422B (da) | 1968-04-29 |
| FI45043B (da) | 1971-11-30 |
| FI45043C (fi) | 1972-03-10 |
| GB1079467A (en) | 1967-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK115847B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf. | |
| DK130586B (da) | Analogifremgangsmåde til fremstilling af 5-alkyl- eller 5-alkoksybenzimidazol-2-karbamater eller syreadditionssalte deraf. | |
| DK133372B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf. | |
| DK106796C (da) | Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf. | |
| DK134222B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme aminer eller syreadditionssalte deraf. | |
| DK114200B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme, basisk substituerede cycloalkenderivater eller syreadditionssalte deraf. | |
| DK107288C (da) | Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf. | |
| DK114618B (da) | Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf. | |
| DK127599B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf. | |
| DK126592B (da) | Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf. | |
| DK117835B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf. | |
| DK109988C (da) | Fremgangsmåde til fremstilling af basisk substituerede 2-oxo-benzimidazoliner eller syreadditionssalte deraf. | |
| DK115110B (da) | Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf. | |
| DK122327B (da) | Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf. | |
| DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
| DK115703B (da) | Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf. | |
| DK114059B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive benzamidoacetamidinderivater med antidepressiv virkning eller syreadditionssalte deraf. | |
| DK111031B (da) | Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf. | |
| DK124614B (da) | Fremgangsmåde til fremstilling af 3-(3-piperidino- eller morpholinopropionyl)-5-phenylisoxazolderivater eller syreadditionssalte deraf. | |
| DK108394C (da) | Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf. | |
| DK128416B (da) | Analogifremgangsmåde til fremstilling af adrenocorticotropt aktive nonadecapeptidamider eller syreadditionssalte eller kompleksforbindelser deraf. | |
| DK116213B (da) | Fremgangsmåde til fremstilling af dibenzocycloheptenylestre eller syreadditionssalte heraf. | |
| DK121375B (da) | Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf. | |
| DK114964B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf. | |
| DK112658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 1-acyl-substituerede quinolizinforbindelser eller syreadditionssalte deraf. |